Scope |
---|
Across industry, there are a wide variety of quality control (QC) checks for SEND datasets. This is currently done without commonly acknowledged scope and intensity, based on the companies own approaches. For more confidentiality of the quality of SEND dataset across different stakeholders this group targets to:
|
...
|
Project Leads |
---|
...
Jesse Anderson |
...
jesse.anderson@fda.hhs.gov | |
Michael Rosentreter |
...
Key Milestones
Objective | Timeline |
---|---|
Collate a list of questions for the FDA around QCing | Q4 2020 |
Status | ||||
---|---|---|---|---|
|
Explored the Variety of QC procedures amongst team members and came up with recommendations.
Project Members | Organisation |
---|---|
Anja Metzger | Bayer |
Brett Coupland | Astrazeneca |
Cathy Roy | Merck |
Christy Kubin | MPI Research |
Daniel Potenta | PDS Lifesciences |
Debra Oetzman | Instem |
Deepika V.G | Point Cross |
Florence Halbert | Novartis |
Gitte Frausing | Data Standards Decisions |
Hepei Chen | FDA |
Jack Baker | Covance |
Jennifer Abbott | Abbvie |
Jennifer Feldmann | Epreda |
Karen Porter | Point Cross |
Kenneth Hershman | Novartis |
Volunteer Today
Our project always welcomes new members to collaborate in an open, transparent and non-competitive project. If you are interested in joining please contact workinggroups@phuse.eu.